Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations
Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.
Risk of anal cancer twice as high for cervical cancer survivors
Anoscopy is the direct visualization of the anus using a speculum. It is used to screen, diagnose, and evaluate perianal and anal...
Study shows two high-dose radiation sessions as effective as standard multi-session treatments for endometrial cancer
High-dose radiation uses of radiation tubes that produce radiation at a fast rate so that the treatment can be completed in minutes....
New drug improves survival in advanced ovarian cancer
CANCER DIGEST – June 24, 2023 – Nearly half of women with advanced ovarian cancer that is resistant to standard chemotherapy survived...
Keytruda boosts survival in advanced cervical cancer as first line therapy
CANCER DIGEST – May 27, 2023 – Women with persistent, recurrent or cervical cancer that has spread to other tissues had improved overall...
New combination therapy shows promise for advanced ovarian cancer
Saturday, February 19, 2022 CANCER DIGEST – Feb. 19, 2022 – Ovarian cancer patients whose tumors have recurred or resisted standard...
